$30,000 of BIODESIX INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Medicare reimbursement for diagnostics. Medicare Contractor Reform. Lab test regulatory and reimbursement reform."
You can find more data on corporate lobbying on Quiver Quantitative.
BDSX Insider Trading Activity
BDSX insiders have traded $BDSX stock on the open market 19 times in the past 6 months. Of those trades, 4 have been purchases and 15 have been sales.
Here’s a breakdown of recent trading of $BDSX stock by insiders over the last 6 months:
- JACK W SCHULER has made 4 purchases buying 3,648,790 shares for an estimated $2,611,422 and 0 sales.
- SCOTT HUTTON (President & CEO) has made 0 purchases and 3 sales selling 4,931 shares for an estimated $10,915.
- ROBIN HARPER COWIE (CFO, Sec'y & Treasurer) has made 0 purchases and 3 sales selling 1,336 shares for an estimated $3,220.
- KIERAN O'KANE (Chief Commercial Officer) has made 0 purchases and 3 sales selling 799 shares for an estimated $2,817.
- GARY ANTHONY PESTANO (Chief Development Officer) has made 0 purchases and 3 sales selling 763 shares for an estimated $2,787.
- CHRIS VAZQUEZ (Chief Accounting Officer) has made 0 purchases and 3 sales selling 324 shares for an estimated $870.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
BDSX Hedge Fund Activity
We have seen 12 institutional investors add shares of BDSX stock to their portfolio, and 23 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- TELEMARK ASSET MANAGEMENT, LLC added 414,124 shares (+inf%) to their portfolio in Q3 2025, for an estimated $3,126,636
- ABERDEEN GROUP PLC added 262,425 shares (+inf%) to their portfolio in Q4 2025, for an estimated $1,784,490
- VANGUARD GROUP INC added 181,904 shares (+inf%) to their portfolio in Q3 2025, for an estimated $1,373,375
- MONASHEE INVESTMENT MANAGEMENT LLC removed 100,000 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $755,000
- SILVERARC CAPITAL MANAGEMENT, LLC removed 53,518 shares (-100.0%) from their portfolio in Q3 2025, for an estimated $404,060
- PERKINS CAPITAL MANAGEMENT INC added 52,633 shares (+inf%) to their portfolio in Q3 2025, for an estimated $397,379
- GSA CAPITAL PARTNERS LLP added 48,342 shares (+inf%) to their portfolio in Q3 2025, for an estimated $364,982
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
